2020年ACC二尖瓣反流管理专家共识决策路径聚焦更新
该文件为美国心脏病学会(ACC)对2017年二尖瓣反流管理专家共识决策路径的聚焦更新,强调识别MR后应评估病因、机制与严重程度,并考虑治疗指征。更新基于继发性MR新试验数据等进展,部分章节更新或新增,提出基于临床表现、超声影像及必要辅助检查的结构化评估以辅助决策。治疗目标包括由经验丰富的多学科心脏团队及时干预,以预防左室功能障碍、心衰、生活质量下降及早亡。
要点
- 识别MR后应评估病因、机制和严重程度,并考虑治疗指征。
- 采用基于临床、超声及必要辅助检查的结构化评估辅助决策。
- 治疗目标为由多学科心脏团队及时干预以预防不良结局。
核心结论
- MR管理应基于病因、机制与严重程度评估,并由多学科心脏团队及时干预以预防左室功能障碍、心衰、生活质量下降及早亡。
研究设计与样本
- 美国心脏病学会(ACC)Solution Set监督委员会发布的专家共识决策路径聚焦更新,对2017年版部分章节更新或新增。
主要发现
- 强调识别MR后应评估病因、机制和严重程度,并考虑治疗指征。
- 基于继发性MR新试验数据等进展,对部分章节进行更新或新增。
- 结构化评估基于临床表现、准确超声心动图成像及必要时的辅助检查,有助于明确决策。
临床怎么用
- 对MR患者应系统评估病因、机制与严重程度,并据此考虑治疗指征。
- 采用临床、超声及必要辅助检查的结构化评估辅助治疗决策。
- 由经验丰富的多学科心脏团队及时干预以改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mitral regurgitation (MR) is a complex valve lesion that can pose significant management challenges. This expert consensus decision pathway emphasizes that recognition of MR should prompt an assessment of its etiology, mechanism, and severity, as well as consideration of the indications for treatment. The document is a focused update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation, with some sections updated and others added in light of the publication of new trial data related to secondary MR, among other developments. A structured approach to evaluation based on clinical findings, accurate echocardiographic imaging, and, when necessary, adjunctive testing can help clarify decision making. Treatment goals include timely intervention by an experienced multidisciplinary heart team to prevent left ventricular dysfunction, heart failure, reduced quality of life, and premature death.
引用
- Bonow RO, O'Gara PT, Adams DH, et al. 2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020. PMID: 32068084. doi:10.1016/j.jacc.2020.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。